Clinical Trial Update: Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer [Phase 1]

View source ↗

Summary

This document reports a completed Phase 1 clinical trial evaluating celecoxib in postmenopausal women undergoing surgery for invasive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CELEBREX (Celecoxib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage I Breast Cancer, Stage II Breast Cancer | Phase 1 | Status: COMPLETED